These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Complications of intravenous therapy. Stephen M; Loewenthal J; Wong J; Benn R Med J Aust; 1976 Oct; 2(15):557-9. PubMed ID: 792652 [TBL] [Abstract][Full Text] [Related]
4. The influence of heparin on intravenous infusions: a prospective study. Tanner WA; Delaney PV; Hennessy TP Br J Surg; 1980 May; 67(5):311-2. PubMed ID: 7388323 [TBL] [Abstract][Full Text] [Related]
6. Heparin and infusion phlebitis. Stradling JR Br Med J; 1978 Oct; 2(6146):1195-6. PubMed ID: 719346 [No Abstract] [Full Text] [Related]
7. A comparison of the rate of complications with heparin-lock and keep-open I.V.'s. Hanson RL Commun Nurs Res; 1977 Mar; 8():188-200. PubMed ID: 585595 [No Abstract] [Full Text] [Related]
8. Complications of intravenous therapy with steel needles and Teflon catheters. A comparative study. Tully JL; Friedland GH; Baldini LM; Goldmann DA Am J Med; 1981 Mar; 70(3):702-6. PubMed ID: 7211903 [TBL] [Abstract][Full Text] [Related]
9. The scalp-vein needle. A prospective study of complications. Crossley K; Matsen JM JAMA; 1972 May; 220(7):985-7. PubMed ID: 5067454 [No Abstract] [Full Text] [Related]
10. Complications with heparin-lock needles: a prospective evaluation of iodophor skin care. Ferguson RL; Hodges GR; Barnes WG APIC; 1979 Mar; 7(1):22-5. PubMed ID: 10240778 [No Abstract] [Full Text] [Related]
11. Heparin lock intravenous line. Use in newborn infants. A controlled trial. Taylor J; Shannon R; Kilbride HW Clin Pediatr (Phila); 1989 May; 28(5):237-40. PubMed ID: 2706885 [TBL] [Abstract][Full Text] [Related]
13. Phlebitis and extravasation ("tissuing") with intravenous infusions. Hecker JF; Fisk GC; Lewis GB Med J Aust; 1984 May; 140(11):658-60. PubMed ID: 6717351 [TBL] [Abstract][Full Text] [Related]
14. Steel needles used for intravenous therapy. Morbidity in patients with hematologic malignancy. Band JD; Maki DG Arch Intern Med; 1980 Jan; 140(1):31-4. PubMed ID: 7352802 [TBL] [Abstract][Full Text] [Related]
15. In vitro contamination of "piggyback/heparin lock" assemblies: prevention of contamination with a closed, positive locking device (Click-Lock). Gibilisco PA; Lopez GA; Appleman MD; Millburg WJ; Kushell DL; Elowitz L; Johnson PA; Zenowich D JPEN J Parenter Enteral Nutr; 1986; 10(4):431-4. PubMed ID: 3747096 [TBL] [Abstract][Full Text] [Related]
16. Central venous thrombosis: a hazard of medical progress. Warden GD; Wilmore DW; Pruitt BA J Trauma; 1973 Jul; 13(7):620-6. PubMed ID: 4715030 [No Abstract] [Full Text] [Related]
17. Efficacy of 0.9% sodium chloride injection with and without heparin for maintaining indwelling intermittent injection sites. Epperson EL Clin Pharm; 1984; 3(6):626-9. PubMed ID: 6509875 [TBL] [Abstract][Full Text] [Related]
18. Heparin in the prevention of infusion phlebitis. A double-blind controlled study. Daniell HW JAMA; 1973 Dec; 226(11):1317-21. PubMed ID: 4586195 [No Abstract] [Full Text] [Related]
19. Prevention of infusion thrombophlebitis. Hessov I Acta Anaesthesiol Scand Suppl; 1985; 82():33-7. PubMed ID: 3904298 [TBL] [Abstract][Full Text] [Related]
20. Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies. Dümichen MJ; Seeger K; Lode HN; Kühl JS; Ebell W; Degenhardt P; Singer M; Geffers C; Querfeld U J Hosp Infect; 2012 Apr; 80(4):304-9. PubMed ID: 22342714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]